Abstract:
Peptides of general formula (I): R 1 -W p -X n -AA1-AA 2 -AA 3 -AA 4 -Y m -R 2 their stereoisomers, mixtures thereof, and/or their cosmetically or pharmaceutically acceptable salts, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment, prevention and/or care of conditions, disorders and/or diseases of the skin, mucous membranes and/or scalp.
Abstract:
Peptides of general formula (I): R 1 -W n -X m -AA 1 -AA 2 -AA 3 -AA 4 -Y p -Z q -R 2 (I) its stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of the skin, mucous membranes and/or hair and the treatment and/or care of those conditions, disorders and/or diseases which are improved or prevented by Hsp stimulation.
Abstract:
Peptides of general formula (I): R 1 -W n -X m -AA 1 -AA 2 -AA 3 -AA 4 -AA 5 -AA 6 -Y p -Z s -R 2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, their preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases that are a consequence of muscle contraction.
Abstract:
Peptides of general formula (I): R 1 -AA 1 -AA 2 -AA 3 -R2 (I) its stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases of the skin and/or hair.
Abstract:
Peptides of general formula (I): R 1 AA 1 -AA 2 -AA 3 -AA 4 -R 2 stereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.
Abstract:
The invention relates to peptide derivatives of general formula (I): R 1 -AA 1 -AA 2 -AA 3 -AA 4 -R 2 (I) their stereoisomers, mixtures thereof, and their cosmetically or pharmaceutically acceptable salts, a method for obtaining them, cosmetic or pharmaceutical compositions containing them and their use for the treatment, care and/or cleansing of those conditions, disorders and/or pathologies of the skin, mucosae, scalp and/or nails resulting from microorganism proliferation or being at risk of microorganism proliferation.
Abstract translation:本发明涉及通式(I)的肽衍生物:R 1 -AA 1 -A A 2 -AA 3 -AA 4 -R 2(I)其立体异构体,其混合物及其化妆品或药学上可接受的盐, 获得它们,含有它们的化妆品或药物组合物及其用于治疗,护理和/或清洁由微生物增殖引起的皮肤,粘膜,头皮和/或指甲的病症,病症和/或病症的风险, 微生物增殖。
Abstract:
Compounds of general formula (I): R 1 -W n -X m -AA 1 -AA 2 -AA 3 -AA 4 -AA 5 -AA 6 -Y p -Z q -R 2 ; their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, and in processes of treatment and/or care of the skin, hair and/or mucous membranes, in particular in the aging and photoaging of the skin.
Abstract:
Peptides with general formula (I): R 1 -AA 1 -AA 2 -AA 3 -AA 4 -R 2 its stereoisomers, mixtures thereof, and its cosmetically or pharmaceutically acceptable saits, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment and/or care of conditions, disorders and/or pathologies of the skin, mucous membranes, scalp and/or hair.
Abstract:
Péptidos de fórmula general R 1 -AA-R 2 capaces de regular Ia exocitosis neuronal, sus estereoisómeros y mezclas de los mismos, racémicas o no, y las sales cosméticamente o farmacéuticamente aceptables de los mismos, en donde AA es una secuencia de 3 a 40 aminoácidos adyacentes contenida en Ia secuencia de aminoácidos de Ia proteína SNAP-25, R 1 se selecciona del grupo formado por H o grupo alquilo, arilo, aralquilo o acilo; y R 2 se selecciona del grupo formado por amino, hidroxilo o tiol, sustituidos o no con grupos alifáticos o cíclicos, con Ia condición de que cuando R 1 es H o acetilo, R 2 no es amino, hidroxilo ni tiol no sustituidos. Un método de obtención, composiciones cosméticas o farmacéuticas que los contienen y su uso para tratar aquellas condiciones que requieran Ia regulación de Ia exocitosis neuronal, preferentemente para tratar Ia piel.
Abstract translation:本发明涉及可以调节神经元胞吐作用的通式为R 1 -A A-R 2的肽,所述肽的立体异构体,外消旋或非外消旋混合物,以及 其美容或药学上可接受的盐,其中:AA是包含在蛋白SNAP-25的氨基酸序列中的具有3-40个相邻氨基酸的序列; R 1选自由H或烷基,芳基,芳烷基或酰基形成的基团; 并且R 2选自由氨基,羟基和硫醇形成的基团,其可以被或可以不被环状或脂肪族基团取代,条件是当R 1是 H或乙酰基,R 2是未取代的氨基,羟基或硫醇。 本发明还涉及获得含有该化妆品或药物组合物的化妆品或药物组合物的方法及其用途,以治疗需要调节神经元胞吐作用的病症,优选治疗皮肤。